2,3:4,6-bis-O-(1-methylethylidene)-α-L-xylo-2-Hexulofuranosonic acid hydrate (1:1), 97%, 100g

2-[4-[2-(BENZIMIDAZOL-2-YLTHIO)ETHYL]PIPERAZIN-1YL]-N-[2,4-BIS(METHYLTHIO)-6-METHYL-3-PYRIDYL]ACETAMIDE DIHYDROCHLORIDE, 95%, 100mg

4-Bromo-2,6-dimethylanisole, 98.0%, 25g

Isopropyl ((R)-(perfluorophenoxy)(phenoxy)phosphoryl)-D-alaninate, 96%, 250mg

(Tetrahydrofuran-2,5-diyl)dimethanol, 95.0%, 100mg

Boîte de pointes de pipettes MARQUE pour pointes de pipettes 1000 µl, 5 pièces

2-Phenoxypyridine-3-carbonyl�chloride, 97.0%, 1g

6,7-Dihydro-5H-pyrrolo[1,2-a]imidazol-6-ol, 95+%, 100mg

N4-Benzoyl-2'-deoxycytidine, 98.0%, 10g

2-Phenoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 1g

7-METHYL-1H-INDAZOL-5-AMINE, 95%, 100mg

Ethyl (3,5-dichlorobenzoyl)acetate, 95.0%, 250mg

(S)-Ethyl 5-oxopyrrolidine-2-carboxylate, 98.0%, 500g